Goldman Sachs Group »

Arbutus Biopharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $317k 127k 2.50
2023-09-30 $415k 205k 2.03
2023-06-30 $511k 222k 2.30
2023-03-31 $820k 271k 3.03
2022-12-31 $895k 384k 2.33
2022-06-30 $2.0M 731k 2.71
2022-03-31 $4.6M 1.5M 2.98
2021-12-31 $2.7M 693k 3.89
2021-09-30 $1.2M 287k 4.29
2021-03-31 $149k 45k 3.34
2020-12-31 $210k 59k 3.54
2020-09-30 $795k 254k 3.13
2020-06-30 $3.0M 1.7M 1.82
2019-12-31 $239k 86k 2.78
2019-09-30 $160k 104k 1.53
2019-06-30 $418k 201k 2.08
2019-03-31 $790k 221k 3.58
2018-12-31 $335k 87k 3.83
2018-09-30 $856k 91k 9.45
2018-06-30 $2.6M 353k 7.30
2018-03-31 $533k 107k 5.00
2017-12-31 $275k 55k 5.04
2017-06-30 $330k 92k 3.60
2017-03-31 $785k 242k 3.25
2016-12-31 $892k 364k 2.45
2016-09-30 $2.1M 610k 3.44
2016-06-30 $2.4M 681k 3.48
2016-03-31 $3.1M 749k 4.13
2015-12-31 $3.0M 675k 4.45
2015-09-30 $4.3M 705k 6.09